Atlas Trials

A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy

Clinical trial NCT06706752 · RECRUITING

Trial details

NCT number
NCT06706752
Sponsor
Sutter Health
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Cancer
Start date
2025-01-24
Primary completion
2025-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.